Oppenheimer Asset Management Inc. Nevro Corp Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$7.96 - $13.59 $2,483 - $4,240	312 Added 1.02%	31,039 $261,000
Q1 2024 May 06, 2024	BUY	$13.56 - $20.78 $129,986 - $199,197	9,586 Added 45.34%	30,727 $443,000
Q4 2023 Feb 13, 2024	BUY	$14.18 - $22.31 $56,379 - $88,704	3,976 Added 23.16%	21,141 $454,000
Q3 2023 Nov 07, 2023	BUY	$18.22 - $25.85 $8,800 - $12,485	483 Added 2.9%	17,165 $329,000
Q2 2023 Aug 02, 2023	BUY	$22.62 - $39.32 $40,964 - $71,208	1,811 Added 12.18%	16,682 $424,000
Q1 2023 May 10, 2023	BUY	$30.17 - $41.11 $7,150 - $9,743	237 Added 1.62%	14,871 $537,000
Q4 2022 Feb 06, 2023	BUY	$36.43 - $49.4 $199,818 - $270,959	5,485 Added 59.95%	14,634 $579,000
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $199,681 - $260,430	-4,911 Reduced 34.93%	9,149 $426,000
Q2 2022 Aug 08, 2022	BUY	$40.85 - $77.67 $74,101 - $140,893	1,814 Added 14.81%	14,060 $616,000
Q1 2022 May 12, 2022	BUY	$59.95 - $92.06 $67,623 - $103,843	1,128 Added 10.15%	12,246 $886,000
Q4 2021 Feb 02, 2022	SELL	$81.07 - $121.29 $336,764 - $503,838	-4,154 Reduced 27.2%	11,118 $901,000
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $56,808 - $92,662	-557 Reduced 3.52%	15,272 $1.78 Million
Q2 2021 Aug 03, 2021	BUY	$141.6 - $179.06 $187,336 - $236,896	1,323 Added 9.12%	15,829 $2.62 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $72,514 - $99,470	546 Added 3.91%	14,506 $2.02 Million
Q4 2020 Feb 11, 2021	SELL	$138.17 - $184.34 $63,005 - $84,059	-456 Reduced 3.16%	13,960 $2.42 Million
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $174,329 - $222,339	1,528 Added 11.86%	14,416 $2.01 Million
Q2 2020 Aug 11, 2020	BUY	$89.45 - $129.85 $323,003 - $468,888	3,611 Added 38.92%	12,888 $1.54 Million
Q1 2020 May 08, 2020	SELL	$70.23 - $144.31 $69,317 - $142,433	-987 Reduced 9.62%	9,277 $928,000
Q4 2019 Feb 07, 2020	SELL	$76.41 - $117.54 $111,100 - $170,903	-1,454 Reduced 12.41%	10,264 $1.21 Million
Q3 2019 Oct 31, 2019	BUY	$61.52 - $91.1 $108,828 - $161,155	1,769 Added 17.78%	11,718 $1.01 Million
Q2 2019 Aug 09, 2019	BUY	$58.04 - $66.99 $59,142 - $68,262	1,019 Added 11.41%	9,949 $645,000
Q1 2019 Apr 24, 2019	BUY	$35.52 - $62.62 $213,688 - $376,721	6,016 Added 206.45%	8,930 $558,000
Q4 2018 Jan 30, 2019	BUY	$35.43 - $56.29 $103,243 - $164,029	2,914 New	2,914 $113,000
Q4 2017 Feb 07, 2018	SELL	$65.94 - $93.31 $50,378 - $71,288	-764 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $61,784 - $69,585	764	764 $70,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$17.4 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.8 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$14.3 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.7 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$8.32 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account